Chronic Myelogenous Leukemia

specific

A chronic myeloproliferative neoplasm characterized by the expression of the BCR-ABL1 fusion gene. It presents with neutrophilic leukocytosis. It can appear at any age, but it mostly affects middle aged and older individuals. Patients usually present with fatigue, weight loss, anemia, night sweats, and splenomegaly. If untreated, it follows a biphasic or triphasic natural course; an initial indolent chronic phase which is followed by an accelerated phase, a blast phase, or both. Allogeneic stem

39

Centers

30

Active Trials

$10M

Cancer Funding

Top Centers for Chronic Myelogenous Leukemia(39)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
High-Volume Research Center
86.7
2
NCI Comprehensive
High-Volume Research Center
72.9
3
NCI Comprehensive
High-Volume Research Center
72.0
469.4
5
NCI Comprehensive
Active Research Program
54.9
6
NCI Comprehensive
Active Research Program
54.9
7
NCI Comprehensive
Active Research Program
54.9
8
NCI Comprehensive
Active Research Program
54.9
9
NCI Comprehensive
Active Research Program
54.9
10
NCI Comprehensive
Active Research Program
54.9
11
NCI Comprehensive
Active Research Program
54.9
12
NCI Comprehensive
Active Research Program
54.9
1354.9
14
NCI Comprehensive
Active Research Program
54.9
15
NCI Comprehensive
Active Research Program
54.9
16
NCI Comprehensive
Active Research Program
54.9
17
NCI Comprehensive
Active Research Program
54.9
18
NCI Clinical
Active Research Program
54.9
19
Active Research Program
54.9
20
NCI Comprehensive
Active Research Program
54.9
21
Active Research Program
54.9
22
Active Research Program
54.9
23
NCI Comprehensive
Active Research Program
54.9
24
Active Research Program
54.9
25
Active Research Program
54.9
26
Active Research Program
54.9
27
NCI Comprehensive
Active Research Program
53.3
28
NCI Comprehensive
Active Research Program
52.4
29
NCI Comprehensive
Active Research Program
48.8
30
NCI Comprehensive
33.6
3133.6
32
NCI Comprehensive
33.6
3333.6
3433.6
35
NCI Comprehensive
33.6
3633.6
3733.6
38
BC CancerVancouver, BC
33.6
3933.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →